Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Radiation Research

• Publication date

  2000-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2PMID 10629616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amino acid transport in isolated rat hepatocytes

  2005cited by this paper
• Immunohistochemical study of localization of gamma-glutamyl transpeptidase in the rat brain.

  1998cited by this paper
• Evaluation of boron neutron capture effects in cell culture using sulforhodamine-B assay and a colony assay.

  1998cited by this paper
• Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.

  1998cited by this paper
• Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.

  1998cited by this paper
• Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

  1998cited by this paper
• Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.

  1997cited by this paper
• Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results

  1997cited by this paper
• Boron neutron capture irradiation of the rat spinal cord: histopathological evidence of a vascular-mediated pathogenesis.

  1996cited by this paper
• A PHASE-I DOSE-ESCALATION TRIAL OF BORON NEUTRON CAPTURE THERAPY FOR SUBJECTS WITH METASTATIC SUBCUTANEOUS MELANOMA OF THE EXTREMITIES

  1996cited by this paper
• Characterization of L‐DOPA transport in cultured rat and mouse astrocytes

  1996cited by this paper
• Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.

  1996cited by this paper
• Tumor cell invasion of basement membrane in vitro is regulated by amino acids.

  1996cited by this paper
• Cancer Neutron Capture Therapy

  1996cited by this paper
• Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.

  1994cited by this paper
• Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.

  1994cited by this paper
• A Rapid Method for the Direct Analysis of Boron in Whole Blood by Atomic Emission Spectroscopy

  1993cited by this paper
• Recent advances in mammalian amino acid transport.

  1993cited by this paper
• Interaction Between the Glutamine Cycle and the Uptake of Large Neutral Amino Acids in Astrocytes

  1993cited by this paper
• Effect of Intracellular Glutamine on the Uptake of Large Neutral Amino Acids in Astrocytes: Concentrative Na+‐Independent Transport Exhibits Metastability

  1992cited by this paper
• Intracellular Boron Uptake and Distribution of BSH and BPA Determined Using Ion Microscopy

  1992cited by this paper
• Advances in the Control of Human Cutaneous Primary and Metastatic Melanoma by Thermal Neutron Capture Therapy

  1992cited by this paper
• Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy.

  1991cited by this paper
• A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit.

  1991cited by this paper
• Role of amino acid transport and countertransport in nutrition and metabolism.

  1990cited by this paper
• Transport of L-tyrosine by B16/F10 melanoma cells: the effect of the intracellular content of other amino acids.

  1990cited by this paper
• High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes

  1989cited by this paper
• Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy.

  1987cited by this paper
• Boron-Neutron Capture Therapy for Tumors

  1986cited by this paper
• Pretreatment effects on the uptake/retention kinetics of L-dopa in Harding-Passey melanoma.

  1986cited by this paper
• Regulation of amino acid transport system L in Chinese hamster ovary cells.

  1982cited by this paper
• The transport of neutral amino acids in cultured human fibroblasts.

  1980cited by this paper
• Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection.

  1975cited by this paper
• Adaptive regulation of amino acid transport across the cell membrane in avian and mammalian tissues.

  1975cited by this paper
• Energization of amino acid transport, studied for the Ehrlich ascites tumor cell.

  1973cited by this paper
• The temperature dependence of the transport of L‐leucine in human erythrocytes

  1972cited by this paper
• Morphological studies of rat brain tumors induced by N-nitrosomethylurea.

  1971cited by this paper
• Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.

  1968cited by this paper

• Expression rate of LAT1 in high-grade parotid gland carcinoma and potential of BNCT as a treatment option for recurrent parotid gland carcinoma.

  2025cites this paper
• 18F-BPA as a surrogate tracer for BPA in BNCT: comparative analysis of transport mechanisms and biodistribution

  2025cites this paper
• Preparation of targeting materials for a boron-containing polyrotaxane in boron neutron capture therapy

  2025cites this paper
• Poly(vinyl alcohol) enhancing therapeutic effects of 4-l-boronophenylalanine on thoracic tumors in neutron capture therapy.

  2025cites this paper
• L-type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review)

  2025cites this paper
• Relationship between amino acid transporter activity and radioactive iodine therapy efficacy in differentiated thyroid cancer

  2025cites this paper
• Comparison of the Biological Response of a Head and Neck Carcinoma and a Glioblastoma Cell Line Under Neutron Irradiation with BPA Administration

  2025cites this paper
• L-Phenylalanine restriction amplifies boron neutron capture therapy efficacy through increased L-boronophenylalanine uptake and induces activating transcription factor 4 stress response in tumor cell lines

  2025cites this paper
• Alanine-serine-cysteine transporter-targeted small-molecule boron carriers for neutron capture therapy of L-4‑boronophenylalanine-refractory tumors.

  2025cites this paper
• Polyethylene glycol complexed with boronophenylalanine as a potential alternative to fructose-boronophenylalanine complexation to increase cellular uptake for BNCT treatment

  2025cites this paper
• Microneedle-adapted PAMAM-BSH delivery facilitates spatiotemporal matching for melanoma boron neutron capture therapy.

  2025cites this paper
• Effect of Neutron Radiation on 10BPA-Loaded Melanoma Spheroids and Melanocytes

  2025cites this paper
• Boron Nanocomposites for Boron Neutron Capture Therapy and in Biomedicine: Evolvement and Challenges

  2025cites this paper
• Current research trends and hotspots of boron neutron capture therapy: a bibliometric and visualization analysis

  2024cites this paper
• Poly(vinyl alcohol) potentiating an inert D-amino acid-based drug for boron neutron capture therapy.

  2024cites this paper
• Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy.

  2024cites this paper
• Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier

  2024cites this paper
• Translational research of boron neutron capture therapy for spinal cord gliomas using rat model

  2024cites this paper
• Potential of BPA functionalized poly(vinylalcohol)-shelled perfluorobutane nanodroplets towards enhanced boron neutron capture therapy and in-situ dosimetry

  2024cites this paper
• Targeted strategies to deliver boron agents across the blood-brain barrier for neutron capture therapy of brain tumors.

  2023cites this paper
• In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapy.

  2023cites this paper
• Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy

  2023cites this paper
• Investigation of the Impact of L-Phenylalanine and L-Tyrosine Pre-Treatment on the Uptake of 4-Borono-L-Phenylalanine in Cancerous and Normal Cells Using an Analytical Approach Based on SC-ICP-MS

  2023cites this paper
• Calculation of the DNA damage yield and relative biological effectiveness in boron neutron capture therapy via the Monte Carlo track structure simulation

  2023cites this paper
• Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open

  2023cites this paper
• Boron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells.

  2023cites this paper
• Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model

  2023cites this paper
• Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model

  2023cites this paper
• Boron neutron capture therapy for urological cancers

  2022cites this paper
• Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model

  2022cites this paper
• The Anti-Tumor Effect of Boron Neutron Capture Therapy in Glioblastoma Subcutaneous Xenograft Model Using the Proton Linear Accelerator-Based BNCT System in Korea

  2022cites this paper
• Boron Neutron Capture Therapy: Clinical Application and Research Progress

  2022cites this paper
• Boron neutron capture therapy: History and recent advances

  2022cites this paper
• A Review of Boron Neutron Capture Therapy: Its History and Current Challenges

  2022cites this paper
• Polymeric ligands comprising sulfur-containing amino acids for targeting tumor-associated amino acid transporters.

  2022cites this paper
• Quantification of boron in cells for evaluation of drug agents used in boron neutron capture therapy

  2021cites this paper
• Fructose-functionalized polymers to enhance therapeutic potential of p-Boronophenylalanine for neutron capture therapy.

  2021cites this paper
• The Effect of Low-Dose Gamma Irradiation on the Uptake of Boronophenylalanine to Enhance the Efficacy of Boron Neutron Capture Therapy in an Orthotopic Oral Cancer Model

  2021cites this paper
• Does Trans-Stimulation of L-Tyrosine Lead to an Increase in Boron Uptake in Head and Neck Squamous Cell Carcinoma Cells?

  2021cites this paper
• Theranostics in Boron Neutron Capture Therapy

  2021influential citation
• LSU Digital LSU Digital Boron neutron capture therapy of cancer: Current status and Boron neutron capture therapy of cancer: Current status and future prospects future prospects

  2021cites this paper
• Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine

  2020cites this paper
• Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT)

  2020cites this paper
• Boron Neutron Capture Therapy ( BNCT ) Part I : Principles and Challenges of BNCT 1 . BNCT : progression and key milestones

  2020cites this paper
• Synthesis of boronophenylalanine-like aza-amino acids for boron-containing azapeptide precursors

  2020cites this paper
• Non-isotope enriched phenylboronic acid-decorated dual-functional nano-assembles for an actively targeting BNCT drug.

  2020cites this paper
• The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model

  2020cites this paper
• Clinical Veterinary Boron Neutron Capture Therapy (BNCT) Studies in Dogs with Head and Neck Cancer: Bridging the Gap between Translational and Clinical Studies

  2020cites this paper
• Boron neutron capture therapy for clear cell sarcoma.

  2020cites this paper
• Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture Reaction

  2020cites this paper
• Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy

  2020cites this paper
• Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies

  2020cites this paper
• Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates

  2020cites this paper
• Folate-appended cyclodextrin improves the intratumoral accumulation of existing boron compounds.

  2020cites this paper
• In Vitro and In Vivo Test of Boron Delivery Agent for Boron Neutron Capture Therapy

  2020cites this paper
• Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism

  2020cites this paper
• Carrier proteins-based boron delivery to tumor.

  2019cites this paper
• Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS.

  2019cites this paper
• 4-Borono-2-18F-fluoro-l-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research

  2019cites this paper
• Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells

  2019cites this paper
• Title The antiproliferative effect of boron neutron capture therapy ina prostate cancer xenograft model

  2019cites this paper
• Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling

  2019cites this paper
• The Current Status and Perspectives of Delivery Strategy for Boron-based Drugs.

  2019cites this paper
• closo-Dodecaborate-conjugated human serum albumins: preparation and in vivo selective boron delivery to tumor

  2018cites this paper
• Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy

  2018cites this paper
• Medicinal Chemistry of Boron-Bearing Compounds for BNCT- Glioma Treatment: Current Challenges and Perspectives

  2018cites this paper
• Optimizing the Therapeutic Efficacy of Boron Neutron Capture Therapy (BNCT) for Different Pathologies

  2018cites this paper
• Non‐invasive estimation of 10B‐4‐borono‐L‐phenylalanine‐derived boron concentration in tumors by PET using 4‐borono‐2‐18F‐fluoro‐phenylalanine

  2018cites this paper
• Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).

  2018cites this paper
• Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.

  2016cites this paper
• Effect of oxygen pressure during incubation with a 10B-carrier on 10B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of 10B-carriers

  2016cites this paper
• Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [18F]FBPA in human and mouse tumour cell lines.

  2016cites this paper
• Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines

  2015cites this paper
• The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model

  2015cites this paper
• Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy

  2015cites this paper
• Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.

  2015cites this paper
• Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells.

  2015cites this paper
• Boron-Based Drug Design.

  2015cites this paper
• Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2

  2015cites this paper
• Autoradiographic and histopathological studies of boric acid-mediated BNCT in hepatic VX2 tumor-bearing rabbits: Specific boron retention and damage in tumor and tumor vessels.

  2015cites this paper
• Neutron autoradiography to study boron compound microdistribution in an oral cancer model

  2015cites this paper
• Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT.

  2015cites this paper
• Intracellular boron accumulation in CHO-K1 cells using amino acid transport control.

  2014cites this paper
• Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.

  2014cites this paper
• Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis

  2014cites this paper
• Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.

  2014cites this paper
• Accelerator-driven boron neutron capture therapy

  2014cites this paper
• Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular‐scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS)

  2014cites this paper
• Short and long-term exposure of CNS cell lines to BPA-f a radiosensitizer for boron neutron capture therapy: safety dose evaluation by a battery of cytotoxicity tests.

  2013cites this paper
• Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature.

  2013cites this paper
• Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.

  2013cites this paper
• Boron neutron capture in prostate cancer cells.

  2012cites this paper
• Studies on the Possible Application of BNCT to Thyroid Cancer

  2012cites this paper
• Selective uptake of boronophenylalanine by glioma stem/progenitor cells.

  2012cites this paper
• Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

  2012cites this paper
• Novel Pharmacological and Magnetic Resonance Strategies to Enhance Boron Neutron Capture Therapy (BNCT) Efficacy in the Clinical Treatment of Malignant Glioma

  2011influential citation
• Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.

  2011cites this paper
• Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.

  2011cites this paper
• Low dose of gamma irradiation enhanced boronophenylalanine uptake in head and neck carcinoma cells for boron neutron capture therapy.

  2011cites this paper
• Boron Determination in Liver Tissue by Combining Quantitative Neutron Capture Radiography (QNCR) and Histological Analysis for BNCT Treatment Planning at the TRIGA Mainz

  2011cites this paper